Michael Bury is a biopharmaceutical commercial leader with over 10 years of experience leveraging data to generate key insights. Previously, Michael held various director-level positions at AbbVie, leading the Retina and Eye Care portfolio and overseeing marketing for BOTOX Therapeutics. Prior to this, Michael worked at Gilead Sciences in multiple analytical roles, contributing to pricing and payer research across therapeutic areas. Michael began their professional journey after earning a degree in Mechanical Engineering from Stanford University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices